Search

Meet Victoria “Vikki” Mills, Associate Director of Research Administration Operations at Memorial Sloan Kettering, who is deeply satisfied with her work and delighted with her family, which will soon expand — Vikki is expecting her second child in August with her fiancée, Shauna.

… Monday, June 28, 2021 Within two minutes of meeting Victoria “Vikki” Mills, Associate Director of Research Administration Operations at Memorial Sloan Kettering, you recognize that you are in the presence of a powerful, positive force to be reckoned with, someone who is happily and energetically creating

Scientists at Sloan Kettering Institute have discovered that the α6ß4 integrin, one of several receptor proteins, plays a key role in signaling for the formation of new blood vessels for a tumor, a process called tumor angiogenesis. By blocking the signaling activity of the α6ß4 subunit of this integrin on vascular cells, researchers found they could slow the growth of tumors.

… Tuesday, February 8, 2005 Summary Scientists at Sloan Kettering Institute have discovered that the α6ß4 integrin, one of several receptor proteins, plays a key role in signaling for the formation of new blood vessels for a tumor, a process called tumor angiogenesis. By blocking the signaling activity

In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.

… Friday, February 6, 2015 Summary In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could fix nerve damage in cancer patients who need brain radiation. Here at Memorial Sloan Kettering and

Learn about the aspiring scientists who were celebrated this month for completing a unique summer research program.

… Tuesday, August 28, 2018 Nineteen aspiring scientists were celebrated this month for completing a unique summer research program offered by the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences . Four of the students received special recognition for their outstanding performance and

MSK’s sarcoma team is dedicated to developing new approaches for treating people with this rare cancer.

… Wednesday, July 22, 2020 Summary MSK’s sarcoma team is focused on developing new treatments for sarcoma, a rare group of cancers that affect the body’s connective tissues. As one of the world’s most respected comprehensive centers devoted exclusively to cancer, Memorial Sloan Kettering has entire teams

MSK scientists and doctors have the most innovative tools at their disposal to make discoveries and develop better treatments.

… Thursday, January 4, 2018 Summary The breakneck speed at which cancer research and treatment is progressing is driven in large part by critical advances in technology. Our scientists and doctors have the most innovative tools at their disposal to make discoveries and develop better treatments. Here,

In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available for this disease.

… Friday, February 1, 2002 Improves Ability to Make Treatment Decisions In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available

Learn about MSK's specialty in treating neuroendocrine cancers.

… Friday, March 7, 2025 The good news is that treatments for prostate cancer are helping patients live longer. But an unsettling new challenge is emerging: a different and deadlier form of the cancer called neuroendocrine prostate cancer (NEPC). Researchers at Memorial Sloan Kettering Cancer Center (MSK

A powerful therapy called an antibody-drug conjugate has been approved by the FDA for more people with bladder cancer.

… Thursday, December 11, 2025 A powerful treatment is now an option for many more people with  bladder cancer , the fifth most common form of cancer. The U.S. Food and Drug Administration (FDA) on November 21 approved a combination of two drugs —  enfortumab vedotin (Padcev®)  and an immunotherapy drug

Learn about MSK’s Adolescent and Young Adult program, which is uniquely positioned to help patients like Danielle Leventhal.

… Thursday, October 1, 2020 Tyler Wong’s girlfriend first sensed something was off. In April 2020, the couple was cuddling at home when girlfriend Joanhy felt a lump in Tyler’s belly. Tyler felt it too. Thinking it could be a hernia, Joanhy asked the urologist she works for to examine Tyler. The doctor